The FDA has issued letters to eight pharmaceutical manufacturers and 12 distributors warming them to stop marketing and distributing 20 unapproved ergotamine tartrate medications used to treat Migraine attacks and vascular headaches.
Steven Galson, M.D., director of the FDA’s Center for Drug Evaluation and Research (CDER) said,
Read more »"Unapproved drugs pose real risks to the American public... Because they have not been subject to FDA review, the safety, effectiveness, and quality of such pro...
...like triptans (Imitrex, Maxalt, Zomig, etc.) and ergotamines (DHE, Migranal) do. Triptans and... Read more »
...nonsteroidal anti-inflammatories (NSAIDs), “triptans,” ergotamines, and mild narcotics all... Read more »
...stroke on the left hemisphere from an injection of ergotamine in 1990. My family Dr. knowing my... Read more »
......as migraine headaches and cluster headaches). Ergotamine helps narrow widened blood... Read more »
......dopamine drugs affecting liver enzymes that remove ergotamine from your body (such as... Read more »
......as migraine headaches and cluster headaches). Ergotamine helps narrow widened blood... Read more »
......dopamine drugs affecting liver enzymes that remove ergotamine from your body (such as... Read more »
This combination medication is used to treat or prevent a certain type of headache (vascular... Read more »
The U.S. Food and Drug Administration (FDA) has sent warning letters to 20 companies for selling unapproved and potentially dangerous migraine... Read summary »